Verso Capital invest in mobile X-ray technology leader Solutions for tomorrow Ab
The investment will accelerate Solutions for tomorrow’s international expansion plans and launch new growth initiatives, including broadening the product portfolio.
Solutions for tomorrow, a Swedish med-tech company, designs and builds leading mobile X-ray systems that unlock the potential of mobile digital radiography both inside and outside hospitals. The company’s “True X-Ray Mobility” concept includes a customized X-ray system and transport vehicle, providing full out-of-hospital capabilities. Solutions for tomorrow’s unique selling proposition and winning formula against blue-chip competitors is based on three competitive advantages: 1) Outstanding mobility, 2) Revolutionary battery technology and 3) Improved hygiene and safety.
Verso Capital is a Finnish private equity firm specialized in building leading international B2B companies in their respective fields. Today, the firm announced that it has signed an agreement to acquire a majority stake in Solutions for tomorrow through a significant growth capital investment. Verso Capital intends to accelerate the company’s international expansion plans which include bringing their mobile X-ray devices to more patients outside hospitals. Verso Capital will help the company become the leading player in part by developing unique new features.
Solutions for tomorrow has sold more than 300 systems in 25 countries globally. The company offers hospitals and clinics innovative mobile X-ray units that improve the nursing experience and patient safety. The units also allow staff to work more efficiently, with higher flexibility and at a lower cost. They do all this while providing hospital-grade images outside the hospital. The units leverage cutting-edge battery technology developed in-house, are smaller and lighter than other units and can easily be transported in a standard size van, like those used for motorized wheelchairs.
Verso Capital is an active owner that creates growth companies by spinning off or investing in businesses that are ready to take growth leaps internationally. As the majority owner of its portfolio companies and by spending a significant amount of time working with management to solve growth and profitability challenges and re-shaping the business, Verso Capital is able to create long-term sustainable growth for its investments. Verso Capital plans to utilize its extensive operational expertise to accelerate Solutions for tomorrow’s expansion efforts on a global scale.
“We are very happy and proud that Verso Capital is coming on board as a new investor in Solutions for tomorrow. This is an incredible opportunity to improve the care of so many more patients,” says Solutions for tomorrow CEO Mattias Guldstrand. “It is critical to us that any investor shares our vision and we found that in Verso Capital. The capital injection and their long experience in international business will strengthen our services and accelerate growth. We’re diving right into recruitment so we can bring in the talent we need to reach that shared vision. Exciting times are ahead of us!”
“We are excited about the opportunity to work together with the Solutions for tomorrow team and be part of the global growth story,” says Marko Järvinen, Partner at Verso Capital. “The team has already demonstrated the company’s potential to become a global technology leader in the mobile X-ray industry. Solutions for tomorrow’s value-add to hospitals, nurses and patients is truly unique and improves the care processes towards a more patient-friendly and safe environment.”
About Verso Capital
Verso Capital is a growth stage buyout investor that specialises in carve-out situations and complex business situations. We acquire and invest in European B2B companies and businesses that have good growth potential and revenues up to €50m, but currently are suffering from growth bottlenecks. Our team has experience from over 100 carve-out and M&A transactions – we have the necessary know-how and methodology to execute even complicated transactions quickly and efficiently. We are typically a majority investor and spend a considerable amount of our time working together with the management in order to solve growth and profitability bottlenecks. We manage three funds with over €160M of capital, and have offices in Helsinki, Stockholm, and Munich.
Mr. Marko Järvinen
+358 40 553 9588